Quick Facts at a Glance
- Recall Date
- October 9, 2025
- Hazard Level
- HIGH
- Brand
- ibspot
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 2 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- ibspot
- Product type
- Motion Sickness Patch
- Sold at
- Multiple Retailers
- Where affected
- WY, VA
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
October 9, 2025
Reported by FDA DRUG
October 29, 2025
RecallRadar source check
April 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Marketed Without an Approved NDA/ANDA
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact ibspot or your healthcare provider for guidance. Notification method: E-Mail
About This Product
Taoscare Motion Sickness Patches are a transdermal patch product marketed under the ibspot brand. They are sold in 36-count boxes and intended to provide relief from motion sickness.
Why This Is Dangerous
The defect is regulatory in nature. The product was marketed without an approved NDA/ANDA. This constitutes noncompliance with drug approval requirements rather than a physical defect in the patch.
Industry Context
This recall is not described as part of a broader industry pattern by the agency.
Practical Guidance
How to identify if yours is affected
- Locate Taoscare Motion Sickness Patches, 36-count box bearing the ibspot brand.
- Check for the absence of an approved NDA/ANDA labeling note on packaging.
- Note WY and VA distribution as part of the recall footprint.
Where to find product info
Refer to the FDA enforcement recall page linked in the notice for official guidance and status.
What timeline to expect
Refunds or replacements, if offered, typically take several weeks to process after confirmation of eligibility.
If the manufacturer is unresponsive
- Escalate to ibspot via recall notification email
- If still unresponsive, contact FDA/FTC consumer hotlines or file a complaint with CPSC if applicable
- Keep records of all communications and packaging.
How to prevent similar issues
- Always verify NDA/ANDA status for drug products before purchase.
- Look for FDA recall notices and verify product listing before use.
- Consider safer, FDA-approved OTC motion sickness products when shopping.
Documentation advice
Keep packaging, recall notices, and correspondence with the manufacturer. Take photos of packaging and product labels.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
- NDA/ANDA issue
- Distributed in WY and VA
- Active recall as of 2025-10-29
- Recall number D-0098-2026
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
